Related references
Note: Only part of the references are listed.Influenza Virus H5 DNA Vaccination Is Immunogenic by Intramuscular and Intradermal Routes in Humans
J. E. Ledgerwood et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial
Julie E. Ledgerwood et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
Julie E. Ledgerwood et al.
LANCET INFECTIOUS DISEASES (2011)
Filovirus emergence and vaccine development: A perspective for health care practitioners in travel medicine
Uzma N. Sarwar et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2011)
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
J. E. Ledgerwood et al.
VACCINE (2010)
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
Julie E. Martin et al.
VACCINE (2008)
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial
Julie E. Martin et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine
Andrew T. Catanzaro et al.
VACCINE (2007)
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine
Barney S. Graham et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
Julie E. Martin et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine
Kathleen M. Daddario-DiCaprio et al.
JOURNAL OF VIROLOGY (2006)
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs
Nancy J. Sullivan et al.
PLOS MEDICINE (2006)
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates:: an efficacy assessment
KM Daddario-DiCaprio et al.
LANCET (2006)
A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates
DH Barouch et al.
JOURNAL OF VIROLOGY (2005)
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
SM Jones et al.
NATURE MEDICINE (2005)
pH-dependent entry of Severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN
ZY Yang et al.
JOURNAL OF VIROLOGY (2004)
Vaccine research efforts for filoviruses
MK Hart
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2003)
Development of a preventive vaccine for Ebola virus infection in primates
NJ Sullivan et al.
NATURE (2000)
Crystal structure of the matrix protein VP40 from Ebola virus
A Dessen et al.
EMBO JOURNAL (2000)
Share Paper
